Dennis Bastas, co-founder, chief executive and chairman of Arrotex Pharmaceuticals, prefers pre-empting a challenge to trying to exploit an opportunity.
UBS, Minters help Arrotex in $205m McPhersonâs bid
Save
Share
Rich Lister Ruffy Geminder has got a fight on his hands at ASX-listed beauty company and takeover target McPhersonâs.
Pharmaceuticals outfit Arrotex Australia has lobbed a bid for McPhersonâs.Â
Tanya Macheda
About a month since Gallin â a subsidiary of Geminderâs Kin Group â lobbed a $1.34 a share on-market takeover offer at McPhersonâs board, a new bidder emerged from the woodwork on Thursday with a higher offer.
Local pharmaceuticals outfit Arrotex Australia lodged a $1.60 non-binding, indicative proposal this week, which was revealed to shareholders in a McPhersonâs trading update to the ASX on Thursday morning.